For the quarter ended Nov. 3 the Dania Beach, Fla., company reported a net loss of 20 cents a share, flat with the year-earlier quarter. Net sales increased 40% to $1.23 billion.
Analysts surveyed by FactSet were expecting Chewy to report a loss of 16 cents a share on revenue of $1.2 billion.
The company's adjusted loss before interest, taxes, depreciation and amortization was $30.2 million, compared with Wall Street expectations of a loss of $39.5 million.
In addition, gross-profit margin in the quarter was 23.7%, 4.1 percentage points wider than the year-earlier figure. Gross margin for the pharmacy business fattened by more than 6.5 percentage points.
Chewy went public June 14, pricing its IPO at $22 a share. Chewy shares were 0.7% higher after hours. They'd closed the regular session down 3.1% at $24.18. Since the public offering they've traded as high as $41.34, on their first day of trading.
The post-IPO lockup period expires later this week. More than 80% of the company’s shares outstanding are subject to the six-month lockup rule, so once that restriction expires, the stock could be in for some volatility.